Stock Alert: AnPac Bio-Medical Gains On Test Volume, Optimistic Revenue Outlook

By RTTNews Staff Writer   ✉   | Published:

Shares of biotechnology company AnPac Bio-Medical Science Co., Ltd. (ANPC) are surging more than 90% Wednesday morning after the company reported strong demand for its cancer screening tests and set a record in paid test volume in the third quarter.

For FY20, the company sees revenue growth of 100% to $3 million to $3.3 million. Average selling price (ASP) of its cancer screening test in 2020 is expected to increase year-over-year contributing to a higher revenue growth forecast.

The Company plans to release its full year results in early March 2021.

ANPC is currently trading at $6.77. It has traded in the range of $3.15- $12.18 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
JPMorgan Chase Bank, N.A., a unit of JPMorgan Chase & Co., has agreed to pay $250 million penalty over the bank's failure to maintain adequate internal controls and internal audit over its fiduciary business. In a filing with the U.S. Securities and Exchange Commission, the company said JPMorgan Chase Bank has entered into a resolution with the Office of the Comptroller of the Currency or OCC. Sunbeam Products, Inc. recalled about 942,760 units of Crock-Pot 6-Quart Express Crock Multi-Cookers for potential burn hazards, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. These include about 28,330 units sold in Canada. Trying to find the perfect gifts for our loved ones has always been a matter of concern. Walmart.com is set to take the pain out of customers this holiday season by adding new features and categories to the Gift Finder tool, which was introduced last year. This, the retail giant believes, will make online shopping easier for gift givers.